ИНСУЛИНОРЕЗИСТЕНТНОСТЬ И БОЛЕЗНИ СЕРДЦА: ЕСТЬ ЛИ СВЯЗЬ?
- Авторы: Драпкина ОМ1, Смирин ВИ1, Ивашкин ВТ1, Drapkina OM2, Smirin VI2, Ivaschkin VT2
-
Учреждения:
- Клиника пропедевтики внутренних болезней ММА им. И.М. Сеченова, Москва
- Выпуск: № 15 (2009)
- Страницы: 61-65
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/278032
- ID: 278032
Цитировать
Полный текст
Аннотация
Об авторах
О М Драпкина
Клиника пропедевтики внутренних болезней ММА им. И.М. Сеченова, МоскваКлиника пропедевтики внутренних болезней ММА им. И.М. Сеченова, Москва
В И Смирин
Клиника пропедевтики внутренних болезней ММА им. И.М. Сеченова, МоскваКлиника пропедевтики внутренних болезней ММА им. И.М. Сеченова, Москва
В Т Ивашкин
Клиника пропедевтики внутренних болезней ММА им. И.М. Сеченова, МоскваКлиника пропедевтики внутренних болезней ММА им. И.М. Сеченова, Москва
O M Drapkina
V I Smirin
V T Ivaschkin
Список литературы
- An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006;291:H1489-H1506.
- Bandyopadhyay GK, Yu JG, Ofrecio J, et al. Increased p85/55/50 expression and decreased phosphatidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 2005;54:2351-59.
- Barbour LA, Rahman SM, Gurevich I, et al. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 2005;280;37489-94.
- Barbour LA, Shao J, Qiao L, et al. Human placental growth hormone increases expression of p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinonlogy 2004;145:1144-50.
- Boubina S, Abel ED. Diabetic cardiomyopathy revisted. Circulation 2007;115:3213-23.
- Boubina S, Abel ED. Mithochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology 2006;21:250-58.
- Cornier M-A, Bessesen DH, Gurevich I, et al. Nutritional up-regulation of p85α expression is an early molecular manifestation of insulin resistance. Diabetologia 2006;49:748-54.
- Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI-3-kinase - and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000;105:31-20.
- De Meyts P. The insuline receptor: structure and function. Rev Med Liege 2005;60(5-6), 286-90.
- Frittittta L, Youngen Jl, Vignery R, et al. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 1996;39(10)1190-95.
- Garvey WT, Maianu L, Zhu Ju-Hong, et al. Evidence for defects in the trafficking and translocation of GLUT4 transporters in skeletal muscle s a cause of human insulin resistance. J Clin Invest 1998;101:2377-86.
- Giorgino F, Perini MT, Smith RJ. Specific increase in p85 α expression in response to dexamethazone is associated with inhibition of insulin-like growth factor-1 stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. J Biol Chem 1997;272:7455-63.
- Hansen BC, Shafrir E. Insulin resistance and insulin resistance syndrome. Frontiers in Animal Diabetes Research, 2002.
- Kim J, Montagnani M, Kon Koh K, et al. Recirocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-904.
- Lamia KA, Peroni OD, Kim Y-B, et al. Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase β-/- mice. Mol Cell Biol 2004;24:5080-87.
- Li Y, Soos TJ, Li X, et al. Protein kinase C inhibits insulin signaling by phosphorylation IRS1 at Ser 1101. J Biol Chem 2004;279:45304-07.
- Makaryus AN, Akhrass P, McFarlane SJ. Treatment of hypertension in metabolic syndrome: implications of recent clinical trials. 2009;9:229-37.
- Nandi A, Kitamura Y, Kahn R, et al. Mouse Models of insulin resistance. Physiol Rev 2004;84:623-47.
- Parakhi RA, Ouyang J, Ochs RS. A New Mechanism of Action for Metformin. 2009;23(1):856.
- Pessini JE, Saltiel A. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2002;106:165-69.
- Peraldi P, Spiegelman BM. Studies of the mechanism of inhibition of insulin signaling by tumor necrosis factor-a. J Endocrinol 1997;155:219-20.
- Reaven GM, Laws A. Insulin resistance: The metabolic Syndrome. Humana Press, 1999.
- Rhee MK, Umpierrez GE. Improving Insulin Sensitivity: A Review of New Therapies. Clinical Cornerstone 2008;9(Suppl. 2):S28-S38.
- Scarpello JHB, Howlett HCS. Metformin therapy and clinical uses. Diabetes Vasc Dis Res 2008;5(1):57-67.
- Young J, Mormons-Trabut L, Couzinet B, et al. Type A insulin resistance syndrome revealing a novel lamin. A Mutation Diabetes 2005;54:1873-78.
- Zeitler PS. Nadeau Insulin resistance: childhood precursors and adult disease. Humana Press, 2008.
- Дедов И.И., Шестакова М.В. Сахарный диабет и артериальная гипертензия. М., 2006. C. 320-329.
- http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2405&mid=1085056570&magid=179